<p>The emergence of antibiotic-resistance is a serious concern in maintaining global health in this era, which necessitates constant advancements in antibacterial research for effective antibacterial solutions. To address this issue, a series of oxazolidinone derivatives bearing biologically significant functionalities were efficiently synthesized and screened for in vitro antimicrobial activities against four bacterial strains viz. two Gram positive strains: <i>S. aureus</i>, <i>S. pyogenes</i>, two Gram negative strains: <i>E. coli</i>, <i>P. aeruginosa</i>, and two fungal strains namely, <i>C. albicans</i>, <i>A. niger</i>, in comparison to standard drugs like Ampicillin and Nystatin, respectively. Further, DFT study were performed and these compounds were screened for their binding efficacies against the respective target proteins, followed by prediction of drug-likeness and ADME properties. Among the oxazolidinone derivatives, compounds <b>7&#xa0;g</b> and <b>7i</b> display excellent activity. Interestingly, <b>7&#xa0;g</b> emerged as a promising candidate, demonstrating better effectiveness against <i>E. coli</i> (12&#xa0;µg/mL), <i>P. aeruginosa</i> (20&#xa0;µg/mL) and <i>S. aureus</i> (50&#xa0;µg/mL) compared to reference drug Ampicillin. Compound <b>7a</b> exhibited excellent activity against <i>A. niger</i> and <i>C. albicans</i> with an MIC of 50&#xa0;µg/mL and 100&#xa0;µg/mL compared to Nystatin (MIC = 100&#xa0;µg/mL). Molecular Dynamics simulations were performed on the target protein for <b>7&#xa0;g</b>, demonstrating exceptional biological activity and binding affinity in in silico studies. These results suggest that oxazolidinone derivative <b>7&#xa0;g</b>,<b> 7i</b> and <b>7k</b> is a promising therapeutic candidate for drug-resistant bacterial and fungal infections.</p> Graphical abstract <p></p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Exploring Oxazolidinone scaffolds for future antibiotics: synthesis and computational insights with DFT, docking, ADME and MD simulation

  • Sanjay Soni,
  • Khushbu Patil,
  • Sharad Gavale,
  • Soyeb Pathan,
  • Rasana Yadav,
  • Prashant R. Murumkar,
  • Rahul Kadu

摘要

The emergence of antibiotic-resistance is a serious concern in maintaining global health in this era, which necessitates constant advancements in antibacterial research for effective antibacterial solutions. To address this issue, a series of oxazolidinone derivatives bearing biologically significant functionalities were efficiently synthesized and screened for in vitro antimicrobial activities against four bacterial strains viz. two Gram positive strains: S. aureus, S. pyogenes, two Gram negative strains: E. coli, P. aeruginosa, and two fungal strains namely, C. albicans, A. niger, in comparison to standard drugs like Ampicillin and Nystatin, respectively. Further, DFT study were performed and these compounds were screened for their binding efficacies against the respective target proteins, followed by prediction of drug-likeness and ADME properties. Among the oxazolidinone derivatives, compounds 7 g and 7i display excellent activity. Interestingly, 7 g emerged as a promising candidate, demonstrating better effectiveness against E. coli (12 µg/mL), P. aeruginosa (20 µg/mL) and S. aureus (50 µg/mL) compared to reference drug Ampicillin. Compound 7a exhibited excellent activity against A. niger and C. albicans with an MIC of 50 µg/mL and 100 µg/mL compared to Nystatin (MIC = 100 µg/mL). Molecular Dynamics simulations were performed on the target protein for 7 g, demonstrating exceptional biological activity and binding affinity in in silico studies. These results suggest that oxazolidinone derivative 7 g, 7i and 7k is a promising therapeutic candidate for drug-resistant bacterial and fungal infections.

Graphical abstract